TaiMed Biologics Inc (中裕新藥) swung into profit in the second quarter on rising sales of its Trogarzo HIV treatment in the US, improving gross margin and recovering value of its financial assets, the company said on Friday.
Net profit in the second quarter was NT$30.42 million (US$1.03 million), compared with a net loss of NT$83.57 million a year earlier, the company said in a filing with the Taiwan Stock Exchange.
Earnings per share last quarter were NT$0.12.
Consolidated second-quarter revenue gained 15 percent year-on-year to NT$179 million, which could be attributed to a mild increase in the sale prices of Trogarzo and stable growth in sales, TaiMed chief financial officer Jack Chen (陳怡成) told the Taipei Times by telephone.
“Revenue could have grown more during the April-to-June period if there had been no COVID-19 outbreaks... With the spread of the disease accelerating in the US since March, some patients could not go to hospitals due to lockdown measures,” Chen said.
Trogarzo is a fourth-line treatment and is not often recommended to patients unless they have already tried the initial or second-line treatments, the company said.
As a result, revenue contribution from the drug is expected to grow mildly rather than rapidly, Chen said.
The company’s gross margin increased to 42 percent in the second quarter, from 17 percent a year earlier, as its contract manufacturer, China-based WuXi Biologics Co (無錫生物製藥), improved its production procedures, he said.
“Given that our gross margin has remained above 40 percent for four quarters in a row, it seemed that it is not an issue anymore for TaiMed. I expect the figure to continue hovering between 40 percent and 50 percent in the second half of this year,” he said.
TaiMed owns 2.3 million shares of Montreal-based Theratechnologies Inc — its marketing and distribution partner — whose rising share price during the second quarter, amid a bullish financial market, buoyed TaiMed’s asset valuation, Chen said.
In the first half of the year, TaiMed reported a net loss of NT$44.95 million, or a net loss per share of NT$0.18, its data showed.
“Overall, we fared well in the second quarter and hope the momentum will continue in the second half of this year, when the pandemic is expected to slow, and our marketing activities would resume soon,” Chen said.
The company expects to break even for the whole of this year, he said.
The company would delay its plan to market Trogarzo in Germany later this quarter, depending on the situation of the outbreak, he added.
European Central Bank (ECB) President Christine Lagarde is expected to step down from her role before her eight-year term ends in October next year, the Financial Times reported. Lagarde wants to leave before the French presidential election in April next year, which would allow French President Emmanuel Macron and German Chancellor Friedrich Merz to find her replacement together, the report said, citing an unidentified person familiar with her thoughts on the matter. It is not clear yet when she might exit, the report said. “President Lagarde is totally focused on her mission and has not taken any decision regarding the end of
French President Emmanuel Macron told a global artificial intelligence (AI) summit in India yesterday he was determined to ensure safe oversight of the fast-evolving technology. The EU has led the way for global regulation with its Artificial Intelligence Act, which was adopted in 2024 and is coming into force in phases. “We are determined to continue to shape the rules of the game... with our allies such as India,” Macron said in New Delhi. “Europe is not blindly focused on regulation — Europe is a space for innovation and investment, but it is a safe space.” The AI Impact Summit is the fourth
CONFUSION: Taiwan, Japan and other big exporters are cautiously monitoring the situation, while analysts said more Trump responses ate likely after his loss in court US trading partners in Asia started weighing fresh uncertainties yesterday after President Donald Trump vowed to impose a new tariff on imports, hours after the Supreme Court struck down many of the sweeping levies he used to launch a global trade war. The court’s ruling invalidated a number of tariffs that the Trump administration had imposed on Asian export powerhouses from China and South Korea to Japan and Taiwan, the world’s largest chip maker and a key player in tech supply chains. Within hours, Trump said he would impose a new 10 percent duty on US imports from all countries starting on
STRATEGIC ALLIANCE: The initiative is aimed at protecting semiconductor supply chain resilience to reduce dependence on China-dominated manufacturing hubs India yesterday joined a US-led initiative to strengthen technology cooperation among strategic allies in a move that underscores the nations’ warming ties after a brief strain over New Delhi’s unabated purchase of discounted Russian oil. The decision aligns India closely with Washington’s efforts to build secure supply chains for semiconductors, advanced manufacturing and critical technologies at a time when geopolitical competition with China is intensifying. It also signals a reset in relations following friction over energy trade and tariffs. Nations that have joined the Pax Silica framework include Japan, South Korea, the UK and Israel. “Pax Silica will be a group of nations
RSS